# Do Microclots Go Away? What the Research Does and Doesn't Show

> Do microclots go away? No study has followed untreated people over time, so no timeline exists. Here's how clots clear and what the data allows.

Canonical: https://amyloid-test.com/resources/do-microclots-go-away/
Last updated: 2026-11-18
Author: Tim Ottowitz
Evidence level: review

**Short answer:** Nobody knows yet. No published study has measured microclots in the same untreated people over time, so there is no evidence-based timeline. Lab studies describe amyloid fibrin microclots as resistant to plasmin, the enzyme that normally clears clots, which hints they may persist, but that's a hypothesis. Symptom recovery isn't proof they've gone.

## Key takeaways

- No study has repeatedly measured microclots in the same untreated people, so any quoted timeline is a guess.
- Normal clots are cleared by plasmin, while lab work describes amyloid microclots as resistant, with alpha-2-antiplasmin trapped inside them.
- The main before and after data come from an uncontrolled preprint of 91 treated patients, plus single case reports, none of which can show what happens without treatment.
- Most symptoms in a large Israeli cohort of mild COVID resolved within a year, but symptom recovery doesn't tell you whether microclots cleared.
- A repeat test on your own sample is the only way to see change in your own blood, and no one can say yet what a change means.

Nobody has shown whether microclots go away. No published study has measured them repeatedly in the same untreated people, so there is no evidence-based timeline, and any number you see online is a guess. This guide explains why the lab research suggests they might persist, what before and after data exist, and what you can realistically do with that.

## How does the body normally clear a blood clot?

An ordinary clot is a fibrin mesh with platelets woven through it. Once a wound has healed, the body breaks that mesh down with plasmin, an enzyme that cuts fibrin into soluble fragments. This process is called fibrinolysis, and it's the reason most clots don't last forever.

Plasmin is kept in check by inhibitors, including alpha-2-antiplasmin, so the system stays balanced. For a longer look at how microclots differ from this picture, see [what microclots are](https://amyloid-test.com/resources/what-are-microclots/) and [microclots versus ordinary blood clots](https://amyloid-test.com/resources/microclots-vs-blood-clots/).

## Why are amyloid microclots described as resistant?

The research that named these particles reports that they don't break down the way normal clots do. In a 2021 lab study, researchers compared plasma from 13 healthy controls, 10 people with type 2 diabetes, 15 with acute COVID-19 and 11 with Long COVID. Plasma from the COVID and Long COVID groups left deposits behind after enzyme digestion that control plasma did not. Those deposits held trapped alpha-2-antiplasmin, the plasmin inhibitor, along with fibrinogen chains and serum amyloid A ([Pretorius et al., Cardiovascular Diabetology 2021](https://doi.org/10.1186/s12933-021-01359-7)).

The same paper reports the deposits could be solubilised after a second round of digestion. So "resistant" means harder to clear, not impossible to clear, at least in a lab dish.

Two more lab studies point the same way. An in vitro study added spike protein S1 to healthy plasma and found fibrin(ogen) that resisted digestion ([Grobbelaar et al., Bioscience Reports 2021](https://doi.org/10.1042/BSR20210611)). A 2025 study using purified proteins found that fibrin clots formed with Spike685 amyloid fibrils resisted plasmin ([Biochemistry 2025](https://doi.org/10.1021/acs.biochem.5c00550)). Both are test-tube findings, covered in more depth in our piece on [spike amyloid fibrils and fibrinolysis](https://amyloid-test.com/resources/spike-protein-amyloid-fibrils-fibrinolysis/).

## How each type of clot is cleared

| | Normal clot | Amyloid fibrin microclot (as described in lab studies) |
|---|---|---|
| Main structure | Fibrin mesh with platelets | Fibrin(ogen) in an amyloid-like, beta-sheet-rich form |
| Cleared by | Plasmin (fibrinolysis) | Reported to resist plasmin and trypsin digestion in vitro |
| Role of alpha-2-antiplasmin | Keeps plasmin in balance | Found trapped inside the deposits in Long COVID plasma |
| Evidence base | Standard physiology | A handful of lab studies, some in vitro only |
| Known timeline | Days to weeks for most clots | None published |

## Is there any before and after data?

Very little, and none of it answers the untreated question. The closest thing is a preprint of 91 South African patients with Long COVID who gave blood before and after a clinician-chosen regimen of two antiplatelet drugs, an anticoagulant and a stomach protector. The authors report that symptoms resolved in the majority and that microclot severity and platelet activation decreased ([Research Square preprint, 2023](https://doi.org/10.21203/rs.3.rs-2697680/v1)).

That result has hard limits. It's a preprint, it had no control group, and everyone was treated, so it can't tell you what would have happened without drugs. The authors themselves caution that such a regimen should only be followed under expert supervision because of bleeding risk. Whether to take any of these medicines is a decision for your clinician, and our [microclots treatment overview](https://amyloid-test.com/resources/microclots-treatment/) covers what's known.

Other studies compare different people at one moment. The 2021 study above looked at acute COVID and Long COVID groups side by side, which isn't the same as watching one person recover. A 2026 UK letter in HemaSphere sampled 151 people with never-hospitalised Long COVID and recovered controls at a median of 483 to 596 days after infection. It found no difference in fibrinolysis tests, and none in the number or area of fibrin(ogen) microaggregates in 55 samples analysed, most of which, controls included, contained some ([Fraser et al., HemaSphere 2026](https://doi.org/10.1002/hem3.70501)). It's one cross-sectional snapshot, and it doesn't show clearance either.

## Where scientists disagree

The 2023 Cochrane review (Fox et al.) found amyloid fibrin(ogen) particles in people with post-COVID condition, healthy individuals and people with diabetes, and called "microclots" an incorrect term for what's being measured ([Cochrane 2023](https://doi.org/10.1002/14651858.CD015775)). If healthy people carry similar particles, "do they go away" becomes a harder question, because the baseline isn't zero.

The researchers who first described the particles reply that they are far more common in Long COVID plasma than in controls and resist fibrinolysis because they are amyloid, and a 2024 reply in Research and Practice in Thrombosis and Haemostasis makes that case ([Kell et al., 2024](https://doi.org/10.1016/j.rpth.2024.102566)). Our [overview of the evidence debate](https://amyloid-test.com/resources/are-microclots-real/) lays out both sides. Neither side has longitudinal data.

## What do we know about Long COVID recovery over time?

Symptoms and microclots are separate questions. In a retrospective Israeli cohort of 1,913,234 health-fund members with mild COVID-19, most of the long COVID outcomes studied had resolved within a year of diagnosis, though anosmia, cognitive impairment, dyspnoea, weakness and palpitations stayed more common than in uninfected people at 180 to 360 days ([Mizrahi et al., BMJ 2023](https://doi.org/10.1136/bmj-2022-072529)).

That study tracked diagnoses in medical records, not blood. It says nothing about microclots, and recovery in a population doesn't predict recovery in one person. Feeling better doesn't prove particles cleared, and persistent symptoms don't prove they remain.

## Do microclots come back?

Untested. Without repeated measurements, there's no data on recurrence. If something that drives microclot formation continues, for instance ongoing infection or persistent spike protein, it's plausible they'd return, but that's inference from the lab models, not an observed result.

## What can you actually do?

Track your symptoms in a simple diary: what, how bad, how often, and what makes it worse. That gives you and your clinician something concrete, whatever any blood test shows. Ask for standard medical review too, because many conditions cause the same symptoms.

Don't start, stop or combine any blood thinner, antiplatelet or enzyme supplement on your own. That decision belongs with a clinician who knows your history. And treat sudden chest pain, severe breathlessness, one-sided weakness, confusion or a swollen painful leg as emergencies, because they can signal a large clot or stroke ([NHS](https://www.nhs.uk/conditions/blood-clots/)). Our guide on [whether microclots are dangerous](https://amyloid-test.com/resources/are-microclots-dangerous/) lists the red flags.

## Can a repeat test show whether yours have changed?

If you want to see change in your own sample, the method has to be the same both times. A first and a second observational test, run the same way, is the only approach that compares your blood with your blood. There's no validated cutoff, so a difference is a data point, not a verdict, and no one can promise it would change your care. Our [guide to microclot testing](https://amyloid-test.com/resources/how-to-test-for-microclots/) and the [amyloid fibrin test explainer](https://amyloid-test.com/resources/amyloid-fibrin-test/) cover the options and their limits.

Our at-home [amyloid test](https://amyloid-test.com/) uses Thioflavin T fluorescence microscopy on a dried finger-prick sample, with results in a Videographic Microscopy Report. Kits keep indefinitely, so a second kit can be saved for a retest to compare before and after. It's not a diagnostic test, it hasn't been validated against the venous platelet-poor-plasma method used in the research, and it doesn't tell you what your result means for treatment.

## FAQ

### Do microclots go away on their own?

Nobody knows. No published study has measured microclots in the same untreated people over time. Lab research describes amyloid microclots as resistant to plasmin, the enzyme that clears normal clots, so persistence is plausible, but so is slow clearance by other routes. Anyone quoting a fixed timeline is guessing, and a repeat measurement is the only way to see what happens in one person.

### How long do microclots last after covid?

There is no published answer. Studies compare different people at one time point, such as acute COVID, Long COVID and healthy controls, rather than following the same people. One 2026 UK study sampled people a median of 483 to 596 days after infection and found no difference in microaggregates against recovered controls, but it didn't track individuals over time.

### Can the body break down microclots naturally?

The body clears ordinary clots with plasmin. A 2021 study found that microclots from Long COVID plasma resisted digestion with the enzyme trypsin and held trapped alpha-2-antiplasmin, which blocks plasmin. After a second round of enzyme digestion in the lab, the deposits did dissolve. Whether the body does something equivalent over months is untested.

### Do microclots come back?

No study has tested this. Because nobody has followed the same people with repeated microclot measurements, there is no data on recurrence after clearance. If an exposure that drives microclot formation continues, such as a new infection, it's plausible they could reappear, but that's inference, not a finding.

### How do I know if my microclots are gone?

Symptoms can't tell you. Feeling better doesn't show clearance, and ongoing symptoms don't show persistence. The only way to see change in your own sample is to run the same observational test twice with the same method. There's no validated reference range, so a change is information to discuss with your clinician, not a diagnosis.

## Sources

- [Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin](https://doi.org/10.1186/s12933-021-01359-7) (Cardiovascular Diabetology, 2021)
- [SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19](https://doi.org/10.1042/BSR20210611) (Bioscience Reports, 2021)
- [SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis](https://doi.org/10.1021/acs.biochem.5c00550) (Biochemistry, 2025)
- [Treatment of Long COVID symptoms with triple anticoagulant therapy (preprint)](https://doi.org/10.21203/rs.3.rs-2697680/v1) (Research Square, 2023)
- [No evidence of hypercoagulability, altered fibrinolysis, or increased fibrin(ogen) microaggregates in never-hospitalized long COVID](https://doi.org/10.1002/hem3.70501) (HemaSphere, 2026)
- [Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition](https://doi.org/10.1002/14651858.CD015775) (Cochrane Database of Systematic Reviews, 2023)
- [Fibrinaloid microclots in long COVID: assessing the actual evidence properly](https://doi.org/10.1016/j.rpth.2024.102566) (Research and Practice in Thrombosis and Haemostasis, 2024)
- [Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study](https://doi.org/10.1136/bmj-2022-072529) (BMJ, 2023)
- [Blood clots](https://www.nhs.uk/conditions/blood-clots/) (NHS, 2024)

## Related

- [What Are Amyloid Microclots? Definition, Causes and Evidence](https://amyloid-test.com/resources/what-are-microclots/)
- [How to Test for Microclots: Methods, Labs and Limits](https://amyloid-test.com/resources/how-to-test-for-microclots/)
- [Micro Blood Clots Symptoms: Microclots Symptoms Guide](https://amyloid-test.com/resources/microclots-symptoms-guide/)
